Mission Bio Stock

missionbio.comHealthcareFounded: 2014Funding to Date: $216.72MM

Mission Bio is the developer of the Tapestri Platform which is a single-cell multi-omics platform enabling genotype and phenotype from the same cell and precise detection of heterogeneity in disease progression and treatment response. This company was founded in 2014 by Adam Abate, Adam Sciambi, Charlie Silver and Dennis Eastburn and is headquartered in San Francisco, CA. Mission Bio helps researchers and clinicians unlock single-cell biology to enable the discovery, development, and delivery of precision medicine.

Register for Details

For more details on financing and valuation for Mission Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Mission Bio.

Register Today

Mission Bio investors also invested in these private companies


Management Team

Marcel Roche
Chief Financial Officer
Darrin Crisitello
Chief Commercial Officer
Yan Zhang
Chief Executive Officer
Adam Sciambi
Co-Founder and Senior Director, Technology & Systems

Other companies like Mission Bio in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation